Randomized Clinical Trial Using FDA’s Sentinel Infrastructure: An Analysis Assessing Feasibility

Podium presented at International Society for Pharmacoepidemiology's International Conference on Pharmacoepidemiology and Therapeutic Risk Management, August 26 - August 30, 2017 in Montreal, QC, CA .

Author(s): Crystal Garcia, Noelle M Cocoros, Kevin Haynes, Sean D Pokorney, Hussein R Al-Khalidi, Sana M Al-Khatib, Jeffrey Brown, Jennifer C Goldsack, Thomas Harkins, Hannah Katcoff, Nancy D Lin, Debbe McCall, Vinit Nair, Lauren E Parlett, Ryan Saliga, Cheryl Walraven, Christopher B Granger, Richard Platt

Presenting author: Noelle Cocoros

Abstract

Tags

Analytic: No tags set.

Data Source: No tags set.

Research Focus: No tags set.

Study Design: No tags set.

Funding Transparency

This work was possible through:

Entry last updated (DMY): 02-12-2024.

Disclaimer

The content of this website, including articles, papers, and any other materials, reflects my personal views and opinions. They do not necessarily represent the views or opinions of my employer, colleagues, or any affiliated organizations. Unless explicitly stated otherwise, this content was generated without the use of any generative AI or large language models (LLMs); all information presented here is solely the result of human input and research.

I may provide links to external websites for convenience or reference, but this does not constitute an endorsement of those sites or the content within them. I am not responsible for the content, accuracy, or reliability of any external websites.

All information shared on this website is for informational purposes only and should not be construed as professional advice.

2024 Lauren Elizabeth Parlett, PhD - Epidemiologist. All rights reserved.

site admin | credits